Schott delivers vials to provide more than 1 billion doses of COVID-19 vaccines

Schott's Gujarat-based facility plays a significant role in making vials

143
Schott
The vials were delivered to projects around the world

Global specialty glass leader and pharmaceutical packaging supplier Schott has delivered vials to provide more than 1 billion doses of COVID-19 vaccines. It remains well on track to deliver vials for more than 2 billion vaccine doses through 2021.

The vials were delivered to projects worldwide, focusing on the US, Europe, and Asia. Approximately 90% of approved vaccines rely on Schott vials.

Schott
SCHOTT reaches COVID-19 milestone: Vials for 1 billion vaccine doses delivered. Image credits: SCHOTT

“The reaction of the pharmaceutical community to COVID-19 is a testament to the power of scientific progress,” said Frank Heinricht, CEO of Germany headquartered at Schott AG. “In just under a year, all previous records for vaccine development have been shattered by not just one, but several research groups. The entire industry is successfully working together to ensure an adequate supply. We’re also working with our government partners to evaluate ways to improve the supply chain and expand production capacity.”

Schott’s plant being the best in manufacturing borosilicate glass container 

Schott is one of the world’s leading producers of pharmaceutical containers made from borosilicate glass, the most proven and most widely available material used to store and deliver vaccines and other sensitive medications. The company’s global manufacturing footprint includes five sites dedicated to manufacturing type-1 borosilicate glass tubes and another 16 plants converting the tubes into vials.

In Jambusar, Gujarat, Schott’s plant is one of the five flagship pharmaceutical tubing production sites responsible for catering to India and Asia’s vast demand. Owing to the soaring demand for quality glass packaging products, the company expanded its local tubing production capacity by 20,000 tons within one year. It translates into enough glass for over 3 billion vials. It also has a 50-50 Joint venture in India by the name of Schott-Kaisha, who is a market leader for manufacturing and supplying pharmaceutical packaging products in India.

“This past year, we have together witnessed the global pharmaceutical industry’s resilience and dedication to fight the novel Coronavirus,” said Pawan Kumar Shukla, president of Schott Glass India. “We are proud to be a part of this fight from India, as a leading contributor of quality glass to ensure successful and safe administration of the Covid- 19 vaccines. Despite the challenges faced, our India plant has operated in full capacity within strict safety guidelines while supporting our global clients and growing workforce.”

The company’s multi-year supports the success of the COVID-19 response, $1 billion global investment in pharmaceutical glass and packaging facilities announced early 2019 in response to rising worldwide demand for safer drug packaging. Despite the pandemic, all expansion projects are on track.

 

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here